cultivate(MD)
vcUSAseed series-a
cultivate(MD) is a US-based medical device venture capital fund that invests in early-stage medical device companies. The firm manages multiple funds including Seed Fund I, Seed Fund II, Accelerator Fund, Opportunity Fund, and Focus Fund, focusing on technologies that improve patient outcomes and reduce healthcare system costs. Notable portfolio companies include Embody (acquired 2023), Imascap (acquired 2017), Shoulder Innovations (IPO on NYSE under 'SI' in July 2025), and SPDx.
Medical Device Health Care Medical